Elliptic Laboratories Valuation
Is ELABSO undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ELABSO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate ELABSO's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate ELABSO's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ELABSO?
Key metric: As ELABSO is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is ELABSO's PS Ratio? | |
|---|---|
| PS Ratio | 15.6x |
| Sales | NOK 87.21m |
| Market Cap | NOK 1.36b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 14.8x |
| Enterprise Value/EBITDA | -41.4x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does ELABSO's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 3.1x | ||
OMG Oxford Metrics | 1.8x | 1.7% | UK£84.8m |
IGP Intercede Group | 5.3x | -6.3% | UK£105.3m |
WNWD Windward | 4.2x | 17.1% | UK£108.6m |
PULS Pulsar Group | 1.2x | 6.1% | UK£76.6m |
ELABSO Elliptic Laboratories | 15.6x | 89.3% | NOK 1.4b |
Price-To-Sales vs Peers: ELABSO is expensive based on its Price-To-Sales Ratio (15.6x) compared to the peer average (3.1x).
Price to Sales Ratio vs Industry
How does ELABSO's PS Ratio compare vs other companies in the GB Software Industry?
Price-To-Sales vs Industry: ELABSO is expensive based on its Price-To-Sales Ratio (15.6x) compared to the UK Software industry average (2.1x).
Price to Sales Ratio vs Fair Ratio
What is ELABSO's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 15.6x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate ELABSO's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Kontron
€1.1b
Engages in the provision of internet of things (IoT) solutions in Austria and internationally.
0L9J
€17.59
7D
-2.2%
1Y
-19.0%
Adeia
US$1.3b
Operates as a media and semiconductor intellectual property licensing company in the United States, Canada, Asia, Europe, the Middle East, and internationally.
0M2A
US$11.70
7D
-17.0%
1Y
20.3%
TeamViewer
€1.8b
Develops and distributes remote connectivity solutions worldwide.
0A36
€11.82
7D
5.0%
1Y
-20.3%